Table 2. Patients characteristics of patient undergoing VATS anatomical lung resections before and after ERAS implementation.
| Variables | Controls | ERAS | P value |
|---|---|---|---|
| Number of patients | 50 | 50 | – |
| Age median [range] (years) | 68 [51–81] | 64 [44–87] | 0.07 |
| Sex (F/M) | 32/18 | 26/24 | 0.2 |
| BMI (median) (kg/m2) | 23.5 | 24.9 | 0.4 |
| ASA, n [%] | 0.07 | ||
| I | 0 | 0 | |
| II | 24 [48] | 33 [66] | |
| III | 26 [52] | 17 [34] | |
| Co-morbidity, n [%] | |||
| Cardiac diseases | 9 [18] | 8 [16] | 0.4 |
| Hypertension | 27 [54] | 19 [38] | 0.1 |
| Smoking | 45 [90] | 36 [72] | 0.02 |
| COPD | 14 [28] | 13 [26] | 0.8 |
| Diabetes | 7 [14] | 8 [16] | 0.8 |
| Renal failure | 4 [8] | 2 [4] | 0.4 |
| Alcohol abuse | 7 [14] | 10 [20] | 0.4 |
| Previous malignancy | 17 [34] | 17 [34] | 1 |
| FEV1 (%, mean ± SD) | 81±20 | 92±18 | 0.005 |
| DLCO (%, mean ± SD) | 74±21 | 76±17 | 0.7 |
| NSCLC, n [%] | 48 [96] | 44 [88] | – |
| Metastasis, n [%] | 2 [4] | 6 [12] | 0.1 |
| Stage NSCLC, n | 0.6 | ||
| T1 | 27 | 25 | |
| T2 | 15 | 14 | |
| T3 | 6 | 5 | |
| N0 | 42 | 37 | |
| N1 | 3 | 3 | |
| N2 | 3 | 4 | |
| Segmentectomy, n [%] | 20 [40] | 18 [36] | 0.7 |
| Lobectomy, n [%] | 30 [60] | 32 [64] | – |
| Operation time [range] (min) | 150 [55–303] | 134 [75–285] | 0.04 |
ERAS, enhanced recovery after surgery; VATS, video-assisted thoracic surgery; BMI, body mass index; ASA, American Society of Anesthesiologist; COPD, chronic obstructive pulmonary disease; NSCLC, non-small cell lung cancer; SD, standard deviation.